Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel
Published on 07/03/2025 at 05:02 pm IST
MT Newswires
Share
Share
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.79 USD | -3.58% |
|
+1.97% | +9.54% |
| 29/01 | UBS Adjusts Price Target on Elanco Animal Health to $30 From $27, Maintains Buy Rating | MT |
| 23/01 | Elanco Animal Health Shares Rise After Piper Sandler Upgrade | MT |
Employees
9,225
Sector
Pharmaceuticals
Calendar
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
AAA
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
24.79USD
Average target price
25.92USD
Spread / Average Target
+4.57%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELAN Stock
- News Elanco Animal Health Incorporated
- Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel
Select your edition
All financial news and data tailored to specific country editions
